| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,290 |
6,932 |
$1.27M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,103 |
4,896 |
$1.17M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,197 |
3,010 |
$777K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
906 |
851 |
$590K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
471 |
456 |
$224K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,459 |
1,415 |
$122K |
| 70450 |
Computed tomography, head or brain; without contrast material |
699 |
668 |
$69K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,148 |
1,891 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$1K |
| 96376 |
|
73 |
52 |
$796.07 |
| 73130 |
|
12 |
12 |
$369.27 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,732 |
1,633 |
$227.52 |
| 71046 |
Radiologic examination, chest; 2 views |
720 |
704 |
$201.74 |
| 87400 |
|
2,738 |
2,675 |
$154.85 |
| 71045 |
Radiologic examination, chest; single view |
1,949 |
1,859 |
$152.34 |
| 87430 |
|
1,260 |
1,240 |
$148.19 |
| 80053 |
Comprehensive metabolic panel |
4,284 |
3,882 |
$146.16 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,891 |
1,771 |
$103.58 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,628 |
4,204 |
$27.47 |
| 81003 |
|
3,629 |
3,427 |
$14.92 |
| 81025 |
|
1,569 |
1,505 |
$13.45 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
620 |
518 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,253 |
1,182 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
378 |
360 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,713 |
1,554 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
204 |
189 |
$0.00 |
| 87420 |
|
309 |
302 |
$0.00 |
| 99001 |
|
102 |
99 |
$0.00 |
| 73610 |
|
14 |
14 |
$0.00 |
| 84702 |
|
26 |
26 |
$0.00 |
| 87186 |
|
57 |
55 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
173 |
168 |
$0.00 |
| 93976 |
|
17 |
13 |
$0.00 |
| 84703 |
|
663 |
628 |
$0.00 |
| 84484 |
|
1,349 |
1,229 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
709 |
688 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,779 |
2,605 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,414 |
1,380 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,623 |
2,470 |
$0.00 |
| 83605 |
|
176 |
156 |
$0.00 |
| 85379 |
|
311 |
300 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,196 |
3,118 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,325 |
2,072 |
$0.00 |
| 87088 |
|
550 |
520 |
$0.00 |
| 87081 |
|
1,003 |
988 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
773 |
755 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
182 |
171 |
$0.00 |
| 82150 |
|
429 |
411 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
244 |
223 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
312 |
301 |
$0.00 |
| 83735 |
|
973 |
881 |
$0.00 |
| 83690 |
|
50 |
49 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
59 |
58 |
$0.00 |
| 85027 |
|
26 |
26 |
$0.00 |
| 87077 |
|
33 |
31 |
$0.00 |